assay development

CLEU Diagnostics is a diagnostics company developing the LabSimple platform, described as a generational leap in diagnostics now in the palm of your hand. The company was one of the first companies founded and incubated at Parvizi Surgical Innovation. Its leadership includes physicians, scientists, and diagnostics industry veterans.

design for manufacturabilitydiagnostics developmentinstrument designmicrofluidicsquality assurance for IVD productssystem integration

CN Bio is an Organ-on-a-chip company that enables customers to generate human-specific efficacy, ADME and safety data with its PhysioMimix solutions. PhysioMimix is a suite of hardware, consumables and assay protocols that recreate complex human biology and predict human drug responses. The company also offers contract research services and support packages, and works with pharmaceutical companies and regulators on human-relevant models.

ADMEContract Research Servicesdisease modelingMicrophysiological systems (MPS)Organ-on-a-chip (OOC) assaysSafety toxicology

Dexorgen, Inc. is an advanced biotechnology company headquartered in Maryland focused on drug discovery. It provides live cell based assays for novel compound screening, including patented ACTOne-based phosphodiesterase (PDE) and G-protein coupled receptor (GPCR) cell lines, and states it is the first in the world to produce commercially available cell lines to screen for compounds targeting PDEs. It also provides biochemical assay kits and specialty dyes, and participated in the federal Tox21 collaboration with NIH, EPA and FDA.

cell engineering with CRISPR and shRNAcompound screeningcontract researchlive cell based assaysmechanism of action characterizationprimary cell culturestable cell line development

Cook MyoSite, Inc., a subsidiary of the Cook Group, was established in 2002 to pioneer advancements in cellular technologies. The company is dedicated to commercializing muscle cell therapies and advancing muscle cell technologies, developing autologous muscle-derived cell (AMDC) technologies and the investigational iltamiocel platform. It operates laboratories and cleanroom facilities in Pittsburgh, PA, and offers custom cell solutions and contract research services.

cell preservationcleanroom ISO 7 and ISO 5endotoxin testinggene expression assaysGMP cell manufacturingmycoplasma assayprocess developmentQC analytical testingsterility testingtechnology transfer

Countable Labs develops Countable PCR, a single-molecule counting platform for DNA and RNA quantification that provides direct, precise detection beyond digital PCR. The company offers instruments (Countable 4, Countable 10), reagents, RNA modules, software, and assay services for genomics research applications including cell and gene therapy, oncology and liquid biopsy, molecular diagnostics, viral genome integrity, genome editing QC, and fusion detection. Formerly known as Enumerix.

3D light sheet imaginggenome integrity analysismultiplexingone-step RT-PCRPCRsingle-molecule countingvector copy number quantificationviral titration

Creative Scientist, Inc. develops customized New Approach Methodologies (NAMs), advanced human cell models, and scalable experimental platforms for drug discovery, efficacy assessment, safety evaluation, disease modeling, and mechanism-of-action studies. The company offers assay development, drug discovery and screening, drug safety and toxicology, disease modeling, advanced cell models, and molecular biology and analytical services. It also offers Volteer-96, an automated TEER measurement device, and VecStem endothelial cell culture media.

antibody-drug conjugatesantibody-RNA conjugatesbarrier function assessmentcompound screeningcytotoxicity assessmentdisease modelingformulation stability testinghepatotoxicity assessmenthigh content imaginglead optimizationmechanism-of-action studiesparticle characterizationprotein expression and purificationTEER measurementvascular safety assessmentvirus-mediated gene delivery

Cytoskeleton, Inc. is a supplier of advanced cell biology and protein products, offering user-friendly kits, specialty reagents, and custom services. Since 1994 it has been involved in small G-protein research, launching the first line of small GTPase reagents in consultation with Dr. Alan Hall. The company provides products with over 50,000 product citations and 30+ years serving the scientific community.

compound screeningcustom servicesprotein purificationtarget validation

Diverge Translational Science Laboratory provides rigorous and quantitative assessments of tissue biomarkers and histopathology to support development of treatments for genetic diseases. Its expertise includes neuromuscular, cardiovascular, and neurodegenerative diseases, safety and toxicity studies, planning and coordinating biopsy studies, and regulatory compliance and reporting. The company began in 2022 with 2 founders and 8 employees who moved from academia to industry.

automated image analysisbiopsy study planning and coordinationcapillary westernhistologyregulatory compliance and reportingwestern blot

ElectraDx Molecular provides molecular tools for clinicians, researchers, laboratories, and hospitals. Its product ecosystem includes the Explorer, Frontier, and Discovery Series, offering multiplexed RT-PCR kits, reagents, and kits for research and veterinary testing. The company is led by founder and CEO Jarrod Provins and is based in San Diego, California.

molecular diagnosticsmultiplexed RT-PCRveterinary testing

EnquBio Inc is a San Diego-based drug R&D technology and service company (preclinical CRO) that advances pharmaceutical and biotechnology research through a comprehensive suite of drug discovery solutions. Located in San Diego's biotech hub, it operates state-of-the-art facilities led by an industry-recognized team, offering expertise in exploratory biology, high-throughput screening, SAR studies, in vitro and in vivo pharmacology, immunology-focused studies, biomarker discovery, and clinical sample analysis.

bioanalysisbiomarker discoverycell line generationex vivo pharmacologygene expression analysisgenome editinghigh content screeninghigh-throughput screeningimmunoassayimmunophenotypingin vivo imagingin vivo pharmacologyiPSC platformnon-GLP toxicologyPK/PD analysiswestern blot

Enzymlogic is an analytical contract research organization (CRO) specializing in binding kinetic profiling of compounds for drug discovery. It focuses on the Hit to Lead and Lead Optimization stages, using kinetic profiling assays to identify reversible and irreversible compounds with therapeutic potential. Its patented kinetic screening platform delivers compound-target interaction data such as Kd, kon, koff and residence time, and its COVALfinder platform characterizes binding mechanisms of reversible, reversible covalent and irreversible drugs.

binding kinetics analysishigh-throughput screeningkinetic profilingprotein science

ExciPlex, Inc. invents diagnostic assays, builds detection systems, and supplies critical reference materials for agricultural and environmental monitoring. The company specializes in natural toxins, supplying high purity toxins and complex small molecules, and provides specialty chemical production for high performance diagnostics. It also offers CRO and consulting services to biotech, agtech, and life sciences companies, and develops portable spectroscopic instrumentation.

assay validationconjugation chemistryconsultingdiagnostic assay inventionlibrary design and synthesisportable spectroscopy instrumentationreaction optimizationsynthetic chemistrytoxin purification

Flexomics develops integrated workflows for functional single-cell biology. Its FLEX platform enables researchers to culture, assay, image, and sequence the same cells within a microscope-compatible consumable format, linking live-cell phenotypes to sequencing data from the same cell. The company combines expertise in single-cell sequencing, systems immunology, microscopy, microfluidics, and assay development.

computational analysisfunctional immune profilinglive-cell imagingmicrofluidicssequencingsingle-cell analysis

Foli Bio is building a molecular data layer for gut biology through stool-derived host RNA. Its Foli-seq™ platform profiles host RNA from naturally shed gut epithelial and immune cells to reveal mucosal inflammation, barrier function, disease biology, and therapeutic response, enabling non-invasive longitudinal transcriptomic readouts for translational studies, biomarker discovery, clinical diagnostics, and precision medicine.

biomarker discoveryhost gut transcriptomicsNGS bioinformaticspatient stratificationpharmacodynamic monitoringstool-derived host RNA profiling

Full Moon BioSystems develops antibody microarrays for protein expression and phosphorylation profiling, with a complete assay service. Its arrays have been cited in 300+ peer-reviewed publications, and it serves research labs, universities, and drug discovery teams worldwide from its Sunnyvale, CA lab.

antibody array assay serviceantibody microarray developmentarray scanning and image analysiscustom array printingprotein expression and phosphorylation profiling